PTK2 and breast cancer: In addition to the cellular and functional consequences of the β4 integrin/FAK complex in breast cancer progression, numerous clinical pathophysiological studies have confirmed that either β4 integrin or FAK is often overexpressed in human tumor malignancies, including colorectal and gastric cancers6, 19, 32, 33.